首页|基于PPAR-γ/NF-κB信号通路探讨肺心汤对野百合碱诱导肺动脉高压大鼠模型的作用及机制

基于PPAR-γ/NF-κB信号通路探讨肺心汤对野百合碱诱导肺动脉高压大鼠模型的作用及机制

Exploration of the Effects and Mechanisms of Feixin Decoction on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats Based on PPAR-γ/NF-κB Signaling Pathway

扫码查看
目的 基于过氧化物酶体增殖物激活受体γ/核因子κB(PPAR-γ/NF-κB)信号通路探讨肺心汤(黄芪、桃仁、红花、葶苈子、赤芍等)对野百合碱诱导肺动脉高压(PAH)大鼠模型的作用及机制.方法 将 48 只雄性SD大鼠随机分为正常组、模型组、西地那非组(0.025 g·kg-1)及肺心汤低、中、高剂量组(11.7、23.4、46.8 g·kg-1).采用单次腹腔注射野百合碱溶液(60 mg·kg-1)构建PAH大鼠模型.造模 1h后开始灌胃给药,每日 1 次,连续28 d.检测各组大鼠的血流动力学及超声心动图指标:右心室收缩压(RVSP)、平均肺动脉压(mPAP)、右心肥厚指数(RVHI)、肺动脉加速时间(PAAT)、肺动脉射血时间(PET)、三尖瓣环缩期位移(TAPSE)、右心室舒张末期内径(RVIDd)和右心室前壁厚度(RVAWT);采用HE染色法观察肺小动脉病理改变;免疫荧光法检测大鼠肺动脉中α平滑肌肌动蛋白(α-SMA)表达水平;ELISA法检测血浆白细胞介素 1β(IL-1β)、IL-6、肿瘤坏死因子α(TNF-α)水平;免疫组化和Western Blot法检测PPAR-γ/NF-κB信号通路相关蛋白表达水平.结果 与正常组相比,模型组大鼠的RVSP、mPAP、RVHI、RVIDd及RVAWT显著升高(P<0.01),PAAT、PAAT/PET、TAPSE均显著降低(P<0.01);肺小动脉血管壁明显增厚,肺小动脉管壁厚度占血管直径的百分比、血管壁面积占小动脉总横截面积的百分比均显著升高(P<0.01);肺动脉中α-SMA蛋白免疫荧光的阳性表达率显著升高(P<0.01);血浆IL-1β、IL-6、TNF-α水平显著升高(P<0.01);肺组织中的PPAR-γ蛋白阳性表达率显著降低(P<0.01),NF-κB蛋白阳性表达率显著升高(P<0.01);肺组织中PPAR-γ、IκB-α蛋白表达显著下调(P<0.01);p-NF-κB/NF-κB蛋白表达比值显著升高(P<0.01).与模型组比较,各给药组大鼠的RVSP、mPAP、RVHI、RVIDd和RVAWT均显著降低(P<0.05,P<0.01),PAAT、PAAT/PET、TAPSE均显著升高(P<0.05,P<0.01);血管壁厚度明显降低,肺小动脉管壁厚度占血管直径的百分比、血管壁面积占小动脉总横截面积的百分比均显著降低(P<0.05,P<0.01);肺动脉中α-SMA蛋白免疫荧光的阳性表达率显著降低(P<0.05,P<0.01);血浆IL-1β、IL-6、TNF-α水平均显著降低(P<0.05,P<0.01);肺组织中的PPAR-γ蛋白阳性率表达显著升高(P<0.05,P<0.01),NF-κB蛋白阳性表达率显著降低(P<0.05,P<0.01);肺组织中PPAR-γ蛋白表达显著上调(P<0.05,P<0.01),p-NF-κB/NF-κB蛋白表达比值显著降低(P<0.01);肺心汤高剂量组大鼠肺组织中IκB-α蛋白表达显著上调(P<0.01).结论 肺心汤能改善野百合碱诱导的PAH大鼠肺动脉压力升高、右心功能障碍和肺血管重塑,其机制可能与调控PPAR-γ/NF-κB信号通路抑制炎症反应有关.
Objective To investigate the effect and mechanism of Feixin Decoction(Astragali Radix,Pericae Semen,Carthami Flos,Descurainiae Semen Lepidii Semen,Paeoniae Radix Rubra,etc.)on monocrotaline-induced pulmonary arterial hypertension(PAH)rats based on peroxisome proliferator-activated receptor-γ/nuclear factor-κB(PPAR-γ/NF-κB)signaling pathway.Methods Forty-eight male SD rats were randomly divided into normal group,model group,Sildenafil group(0.025 g·kg-1)and low-,medium-and high-dose of Feixin Decoction groups(11.7,23.4,46.8 g·kg-1).PAH rat model was established by single intraperitoneal injection of monocrotaline solution(60 mg·kg-1).After 1 hour of modeling,the rats were given intragastric administration once a day for 28 days.Hemodynamic and echocardiographic parameters including right ventricular systolic pressure(RVSP),mean pulmonary artery pressure(mPAP),right ventricular hypertrophy index(RVHI),pulmonary artery acceleration time(PAAT),pulmonary artery ejection time(PET),tricuspid annular plane systolic excursion(TAPSE),right ventricular internal diameter(RVIDd)and right ventricular anterior wall thickness(RVAWT)were measured in each group.The pathological changes of pulmonary arterioles were observed by HE staining.The expression level of α-smooth muscle actin(α-SMA)in rat pulmonary artery was detected by immunofluorescence.The levels of plasma interleukin-1β(IL-1β),IL-6 and tumor necrosis factor-α(TNF-α)were detected by ELISA.The expression levels of PPAR-γ/NF-κB signaling pathway-related proteins were detected by immunohistochemistry and Western Blot.Results Compared with the normal group,the RVSP,mPAP,RVHI,RVIDd and RVAWT of the model group were significantly increased(P<0.01).PAAT,PAAT/PET and TAPSE were significantly decreased(P<0.01).The wall of pulmonary arterioles was significantly thickened,and the percentage of wall thickness of pulmonary arterioles to vascular diameter and the percentage of vascular wall area to total cross-sectional area of pulmonary arterioles were significantly increased(P<0.01).The positive expression rate of α-SMA protein in pulmonary artery was significantly increased(P<0.01).The levels of plasma IL-1β,IL-6 and TNF-α were significantly increased(P<0.01).The positive expression rate of PPAR-γ protein in lung tissue was significantly decreased(P<0.01),and the positive expression rate of NF-κB protein was significantly increased(P<0.01).The protein expressions of PPAR-γ and IκB-α in lung tissue were significantly down-regulated(P<0.01).The protein expression ratio of p-NF-κB/NF-κB was significantly increased(P<0.01).Compared with the model group,RVSP,mPAP,RVHI,RVIDd and RVAWT in each administration group were significantly decreased(P<0.05,P<0.01),while PAAT,PAAT/PET and TAPSE were significantly increased(P<0.05,P<0.01).The thickness of the vascular wall was significantly reduced,and the percentage of the wall thickness of the pulmonary arterioles to the diameter of the blood vessels and the percentage of the vascular wall area to the total cross-sectional area of the small arteries were significantly reduced(P<0.05,P<0.01).The positive expression rate of α-SMA protein in pulmonary artery was significantly decreased(P<0.05,P<0.01).The plasma levels of IL-1β,IL-6 and TNF-α were significantly decreased(P<0.05,P<0.01).The positive expression rate of PPAR-γ protein in lung tissue was significantly increased(P<0.05,P<0.01),and the positive expression rate of NF-κB protein was significantly decreased(P<0.05,P<0.01).The protein expression of PPAR-γ in lung tissue was significantly up-regulated(P<0.05,P<0.01),and the protein expression ratio of p-NF-κB/NF-κB was significantly decreased(P<0.01).The protein expression of IκB-α in the lung tissue of rats in the high-dose group of Feixin Decoction was significantly up-regulated(P<0.01).Conclusion Feixin Decoction can improve pulmonary artery pressure,right ventricular dysfunction and pulmonary vascular remodeling in PAH rats induced by monocrotaline.The mechanism may be related to the regulation of PPAR-γ/NF-κB signaling pathway to inhibit inflammatory response.

Feixin Decoctionpulmonary arterial hypertensionPPAR-γ/NF-κB signaling pathwaypulmonary vascular remodelinginflammatory reactionrats

谭骏岚、易健、曹闲雅、王飞英、丁蓉珍、戴爱国

展开 >

湖南中医药大学中西医结合学院,湖南 长沙 410208

血管生物学与转化医学湖南省重点实验室,湖南 长沙 410208

湖南中医药大学第一附属医院医学创新实验中心,湖南 长沙 410021

湖南中医药大学医学院呼吸疾病研究室,湖南 长沙 410208

湖南中医药大学第一附属医院呼吸科,湖南 长沙 410021

展开 >

肺心汤 肺动脉高压 PPAR-γ/NF-κB信号通路 肺血管重塑 炎症反应 大鼠

国家自然科学基金项目湖南省自然科学基金项目中国博士后科学基金面上项目湖南省中医药科研计划重点项目湖南省研究生科学研究创新项目长沙市自然科学基金项目湖南中医药大学中西医结合学院-明康中锦联合基金项目

822000662021JJ300172021M690982C2022001CX20220823kq22022722022MKZJ07

2024

中药新药与临床药理
广州中医药大学

中药新药与临床药理

CSTPCD北大核心
影响因子:0.908
ISSN:1003-9783
年,卷(期):2024.35(3)
  • 23